Oklahoma SB926 mandates Medicaid coverage for insulin and delivery systems, including wearable pumps, effective July 1, 2025.
Oklahoma SB926 requires the state Medicaid program to cover insulin and insulin delivery systems when medically necessary for diabetes management. The covered systems include tubeless, wearable insulin pumps that deliver insulin automatically. The Oklahoma Health Care Authority must seek necessary federal approval to implement this coverage. The act declares an emergency and is set to become effective July 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.